2019 Guidelines on Supraventricular Tachycardia (for the management of patients with)

ESC Clinical Practice Guidelines

Topic(s):

Arrhythmias, General

Atrial Fibrillation

Supraventricular Tachycardia (non-AF)

Guidelines version available to download

Full text

Published in 2019

Reference SVT

Pocket guidelines

Published in 2019

Reference PG TOC

Slide-set

Published in 2019

Reference 2019 Slides on SVT

CME questions

Published in 2019

Reference CME

App

Published in 2019

Reference Pocket Guidelines App

Declarations of interest

Endorsed by cardiac societies

Belgian Society of Cardiology , Cardiology Society of Serbia , German Cardiac Society , Italian Federation of Cardiology , Hungarian Society of Cardiology , Spanish Society of Cardiology , Polish Cardiac Society , Russian Society of Cardiology , Portuguese Society of Cardiology , Turkish Society of Cardiology

Table of contents: Full Text (ESC Clinical Practice Guidelines)

Preamble
Introduction
- Evidence review
- Relationship with industry and other conflicts of interest
- What is new in the 2019 Guidelines?
Definition and lcassification
Electrophysiological mechanisms of supraventricular tachycardia
Cardiac anatomy for the electrophysiologist
Epidemiology of supraventricular tachycardia
Clinical presentation
Initial evaluation of patients with supraventrcular tachycardia
Differential diagnosis of tachycardia
- Narrow QRS (=120ms) tachycardia
  - Electrocardiographic differential diagnosis
  - Vagal manoeuvres and adenosine
  - Electrophysiology study
- Wide QRS (>120ms) tachycardia
  - Electrocardiographic differential diagnosis
  - Electrophysiology study
- Irregular tachycardia
Specific types of supraventricular tachycardia
- Atrial arrhythmias
  - Sinus tachydardia
  - Focal atrial tachycardia
  - Multifocal atrial tachycardia
  - Maro-re-entrant atrial tachycardia
- Atrioventricular junctional arrhythmias
  - Atrialventricular modal re-entrant tachycardia
  - Non-re-entrant junctional tachycardia
- Atrioventricular arrhythmia
  - Accessory pathways
  - Wolff Parkinson White syndrome
  - Orthodromic atrioventricular re-entrant tachycardia
  - Antidromic atrioventricular re-entrant tachycardia
  - Accessory pathway as a bystander
  - Pre-excited atrial fibrillation
  - Concealed accessory pathways
  - Permanent junctional reciprocating tachycardia
  - Atypical forms of pre-excitation (Mahaim fibres)
Supraventricular tachycardia in adults with congenital heart disease
- Pharmacopological antiarrhythmic therapy
- Catheter and surgical ablation
- Specific disease states
  - Atrial septal defect
  - Ebstein's anomaly
  - Transposition of the great arteries
  - Tetralogy of Fallot
  - Fontan repairs
Supraventricular tacycardia in the paediatric population
- Foetal arrhythmias
Supraventricular tachycardia in pregnancy
- Material obstretic and offspring risk
- Therapy
  - Antiarrhythmic drugs
  - Electrical cardioversion
  - Catheter ablation
Tachycardia-induced cardiomyopathy
- Definition
- Mechanism
- Diagnosis
- Therapy
Supraventricular tachycardia in sports
Supraventricular tachycardia and driving restrictions
Key messages
Gaps in evidence
Evidence-based "what to do" and 'what not to do" messages from the Guidelines
Supplementary data
Appendix
References

Previous version available to download

Full text

Published in 2003

Reference ESC Web Site only

Executive Summary

Published in 2003

Reference EHJ 2003;24:1857-1897

Slide-set

Published in 2003

Reference SVA

Show navigation Hide navigation

2019 Guidelines on Supraventricular Tachycardia (for the management of patients with)

ESC Clinical Practice Guidelines